Denali Therapeutics and Royalty Pharma entered a $275 million royalty funding agreement based on future sales of tividenofusp alfa.
Oliver Chu is one of five kids participating in a clinical trial investigating a gene therapy for Hunter syndrome, a disorder with symptoms akin to childhood dementia that limits life expectancy ...
Three-year-old Ollie Chu, born with the rare and life-limiting Hunter syndrome, is showing improvement after receiving an ...
11don MSN
Boy, three, with devastating inherited disorder shows 'amazing' response to world-first gene therapy
Oliver Chu - who has Hunter syndrome, which can be life threatening and mainly affects boys - was treated as part of a trial ...
Ollie Chu travelled from California in the United States to the UK earlier this year to undergo the gene therapy treatment. | ...
Ollie Chu travelled from California in the United States to the UK earlier this year to undergo the gene therapy treatment. | ...
A three year-old boy with a rare life-limiting condition has undergone a groundbreaking new treatment developed in Manchester ...
The parents of a three-year-old boy born with a devastating, life-limiting genetic condition say they are now excited for his ...
The parents of a three-year-old boy born with a devastating, life-limiting genetic condition say they are now excited for his ...
NEW YORK CITY (WABC) -- Two years ago, the Adams administration launched its plan called, the "Healthy NYC Plan," with its goal of making healthy changes so life expectancy could rise to 83 years old ...
What makes the case unique: Toxic squash syndrome is considered very rare, and this was the first such case ever reported in Canada. Similar cases had previously been reported in other countries, such ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback